Fierce Females in Finance Share Tips for Making it in the Banking World
Finance and banking have traditionally been male-dominated fields, but women are breaking through and proving they belong.
Libby Leffler, VP of Membership at SoFi, and Alexandra Taussig, Senior Vice President of Fidelity Investments, were with us to discuss how women can make their way up the ranks in the banking world.
Taussig oversees a team that encourages women to get more financially engaged. She explains the factors holding women back. Taussig said women don't typically consider themselves investors and believe they are too busy. She added that women tend to be less confident than men about investing, despite research that shows women achieve better earnings. "Like Warren Buffett, women tend to buy and hold," said Taussig.
SoFi is focused on making investors feel more confident and educated about investing. Leffler said that female members of SoFi are worried about more than just money. Part of being a SoFi member means you get a career coach, as well as access to 400 plus network events throughout the year. Leffler shared how these events are helping millennials take control of their finances.
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
